FLARE® is special because it is the only technology that has all of the following features, many of which are patent-protected worldwide:
Up to 6 real-time, simultaneous video streams including color, three independent fluorophores of various chemical classes, and merges of 2 or more video streams
Both geometric and mathematical merge capabilities. This enables the use of bright pseudo-colors added to the color video (geometric merge) to quickly find invisible structures, as well as true ratiometric imaging with weighted coefficients (mathematical merge) for environment-sensing contrast agents for pH, redox state, electrical activity, etc.
Single cell detection capability (<25 μm resolution), yet zoom out capabilities to visualize a 9” diagonal
Powerful GPIO interface and scripting language
Ergonomic design of imaging heads, monitors, etc. optimized for human surgery
Dozens of procedure-specific 700 nm and 800 nm FLARE® contrast agents (drugs) optimized for use with FLARE® imaging systems
It is also one of the only technologies that has the potential to someday impact every stakeholder in the healthcare continuum
Researchers: Track stem cells, immune cells, malignant cells, develop improved transplant protocols, develop new NIR fluorescent contrast agents, develop new population-based screening procedures, and reconstruct histopathology in 3-D
Veterinarians: Enhance tumors or normal structures in order to perform precision surgery on pets and other animals
Patients: Complete resection of metastatic cells, tactical avoidance of normal tissues and organs, lower long-term morbidity, shorter anesthesia times
Families: Peace of mind that cancer resection was complete, avoidance of repeat surgeries, potentially shorter recovery times for some surgeries
Surgeons: Better patient outcomes increase referrals, shorter surgery time may mean an additional 1-2 cases per day, thus increased compensation, peace of mind from real-time image-guidance
Hospitals: Shorter anesthesia times results in increased OR turnover, additional cases per day, and additional revenue, fewer complications improve Medicare/Medicaid quality scores
Insurance Companies: Improved cancer resection and surgery with lower complication rates reduce the need for costly re-operations. Avoidance of normal tissues and organs leads to fewer costly long-term morbidities
Healthcare System: Better outcomes and lower morbidities translate into lower overall costs and improved public health
Curadel will be working hard over the next decade to turn this vision into reality
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.